MASLD prevalence, incidence and global aspects.
Saved in:
| Title: | MASLD prevalence, incidence and global aspects. |
|---|---|
| Authors: | Wild SH; Usher Institute of Population Health Sciences, University of Edinburgh, Edinburgh, UK. sarah.wild@ed.ac.uk., Lazarus JV; City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.; Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Spearman CW; Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Ocama P; Makerere University College of Health Sciences, Kampala, Uganda., Bilson J; National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton and University of Southampton, Southampton, UK., Zhou XD; Wenzhou Medical University, Zhejiang, China., Zheng MH; Wenzhou Medical University, Zhejiang, China., Byrne CD; National Institute for Health and Care Research, Southampton Biomedical Research Centre, University Hospital Southampton and University of Southampton, Southampton, UK. c.d.byrne@soton.ac.uk. |
| Source: | Diabetologia [Diabetologia] 2026 May 21. Date of Electronic Publication: 2026 May 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
